@article{bf98fce8090744289d33675480185512,
title = "Antibiotic treatment in cystic fibrosis: Part 1: Introduction: Clinical pharmacokinetics and toxicology",
keywords = "aminoglycoside, aminoglycoside antibiotic agent, amoxicillin plus clavulanic acid, beta lactam antibiotic, colistin, cotrimoxazole, doxycycline, flucloxacillin, fusidic acid, macrolide, pheneticillin, quinoline derived antiinfective agent, quinolone, rifampicin, chronicity, clinical feature, cystic fibrosis, dose calculation, drug bioavailability, drug clearance, drug distribution, drug indication, drug metabolism, genotype, Haemophilus influenzae, human, infection prevention, maintenance therapy, Pseudomonas aeruginosa, respiratory tract infection, review, Staphylococcus aureus, survival rate, treatment indication",
author = "Touw, {Dani{\"e}l J.} and Mouton, {Johan W.} and Vinks, {Alexander A.T.M.M.} and Horrevorts, {Alphons M.} and Heijerman, {Harry G.M.}",
year = "2000",
month = apr,
doi = "10.1016/S1069-417X(00)89003-2",
language = "English",
volume = "18",
pages = "25--29",
journal = "Antimicrobics and Infectious Diseases Newsletter",
issn = "1069-417X",
number = "4",
}